BRCA2 and ovarian serous adenocarcinoma: To assess whether BRCA2 mutations in cancers are associated with decreased expression of identified genes, we analyzed the serous ovarian cancers (SOC) within The Cancer Genome Atlas (TCGA) dataset32.